Iovance Biotherapeutics logo
Iovance Biotherapeutics
IOVA | NASDAQ
Chart Builder DCF Calculator
$7.55
-$0.21 (-2.71%)
At close: Nov 16, 2026, 4:00 PM ET
$7.50
-$0.05 (-0.66%)
Pre-market: Nov 17, 2026, 5:33 AM ET

Iovance Biotherapeutics Income Statement

Income statement explained
Fiscal Quarter
Period Ending
Q3 2026
Sep 30, 2026
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
121.47M 99.31M 71.43M 86.77M 67.46M 59.95M 49.32M 73.69M 58.55M 31.11M 715K 482K 469K 238K – – – – – – – – –
48.03M 43.6M 42.5M 43.11M 38.48M 48.88M 42.72M 45.54M 39.82M 31.37M 7.26M 4.37M 4.34M 2.05M – – – – – – – – –
73.44M 55.72M 28.93M 43.66M 28.98M 11.07M 6.61M 28.15M 18.73M -262K -6.55M -3.88M -3.87M -1.81M – – – – – – – – –
-23.97M -51.91M -81.04M -73.46M -89.76M -113.77M -121.22M -86.58M -89.07M -101.91M -117.72M -121.26M -118.36M -110.09M -110.86M -107.04M -100.4M -99.73M -91.71M -99.47M -86.24M -81.43M -75.57M
2.31M 3.22M 1.33M 1.74M 1.24M 4.1M 3.22M 9.58M 4.01M 3.36M 3.34M 3.12M 3.36M 3.08M 3.49M 1.72M 777K 385K 106K 135K 120K 75K 121K
-21.66M -48.69M -79.71M -71.72M -93.66M -109.67M -118M -77M -85.06M -98.56M -114.38M -118.14M -115M -107.01M -107.37M -105.32M -99.62M -99.35M -91.61M -99.33M -86.12M -81.35M -75.45M
-22.27M -47.32M -79.05M -71.9M -91.25M -111.66M -116.16M -78.56M -83.54M -97.1M -112.98M -116.38M -113.76M -106.53M -107.37M -105.32M -99.62M -99.35M -91.61M -99.33M -86.12M -81.35M -75.45M
38.58M 39.27M 38.95M 36.4M 34.56M 37.57M 43.8M 42.5M 39.55M 34.19M 26.12M 29.9M 26.96M 21.93M 28.12M 26.46M 27.89M 26.33M 23.41M 23.85M 20.89M 19.31M 19.62M
49.34M 58.85M 62.49M 71.2M 75.17M 77.93M 75.97M 72.22M 68.25M 62.08M 79.78M 87.47M 87.53M 86.35M 82.73M 80.57M 72.5M 73.41M 68.3M 75.62M 65.36M 62.12M 55.95M
9.5M 9.5M 8.54M 9.52M 9.01M 9.35M 8.07M – -1K 5.38M 5.27M – – – – – – – – – – – –
97.41M 107.62M 109.98M 117.12M 118.74M 124.85M 127.83M 114.73M 107.8M 101.65M 111.18M 117.37M 114.49M 108.27M 110.86M 107.04M 100.4M 99.73M 91.71M 99.47M 86.24M 81.43M 75.57M
– – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – 17.86M – – – – – – – – – – – –
145.44M 151.22M 152.47M 160.23M 157.21M 173.73M 170.55M 160.27M 147.62M 133.02M 118.44M 121.74M 118.83M 110.32M 110.86M 107.04M 100.4M 99.73M 91.71M 99.47M 86.24M 81.43M 75.57M
614K -1.37M -665K 184K -2.41M 1.99M -1.84M 1.56M -1.52M -1.46M -1.41M -1.76M -1.24M -477K – – – – – – – – –
455.92M 450.19M 418.51M 406.97M 364.04M 334.51M 322.87M 304.89M 303.27M 284.82M 266.22M 255.95M 245.82M 224.48M 213.69M 164.77M 157.82M 157.27M 157.11M 156.92M 155.51M 153.75M 147.37M
455.92M 450.19M 418.51M 406.97M 364.04M 334.51M 322.87M 304.89M 303.27M 284.82M 266.22M 255.95M 245.82M 224.48M 213.69M 164.77M 157.82M 157.27M 157.11M 156.92M 155.51M 153.75M 147.37M
-0.05 -0.11 -0.19 -0.18 -0.25 -0.33 -0.36 -0.26 -0.28 -0.34 -0.42 -0.45 -0.46 -0.47 -0.50 -0.62 -0.63 -0.63 -0.58 -0.63 -0.55 -0.53 -0.51
-0.05 -0.11 -0.19 -0.18 -0.25 -0.33 -0.36 -0.26 -0.28 -0.34 -0.42 -0.45 -0.46 -0.47 -0.50 -0.62 -0.63 -0.63 -0.58 -0.63 -0.55 -0.53 -0.51
-12.16M -41.5M -70.63M -60.82M -78.24M -101.55M -110.29M -65.31M -77.92M -87.7M -104.48M -108.42M -105.13M -99.16M -101.67M -99.61M -94.42M -94.1M -86.63M -87.12M -82.16M -78.57M -72.8M
-21.66M -51.91M -81.04M -73.46M -89.76M -113.77M -121.22M -77M -89.07M -98.56M -114.38M -118.14M -115M -107.01M -107.37M -105.32M -99.62M -99.35M -91.61M -99.33M -86.12M -81.35M -75.57M
9.5M 10.4M 10.42M 12.64M 11.52M 12.23M 10.94M 11.69M 11.15M 10.86M 9.91M 9.71M 9.88M 7.84M 5.7M 5.71M 5.2M 5.25M 4.98M 12.21M 3.97M 2.78M 2.77M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.